Contacts With Patients
To prevent transmission of the virus between patients and safeguard our staff or their families
please do not come to the surgery unless asked after being triaged.
Ring 0115-9208615 and you will be triaged by phone and possibly video triage. We are generally now using accuRx which allows us to have videolinks.
We are also using this to send you documents and ask you questions.
To order prescriptions continue to use SystmOne online ordering, or use the
NHS App or drop in prescription requests through the letter box. We are looking
to transition to repeat dispensing.
11-04-2020 – If patients need to be assessed and have coronavirus symptoms, they may be directed to CMC hubs where they may be assessed.
Similarly if home visits are needed they may be with people related to the Primary Care Network or Others depending on the circumstances
and progression of Coronavirus. This is done to safeguard NHS Staff and the Public.
NHS Immunisations FAQs (for public)
Why aren’t you stopping routine immunisations?
Whilst preventing the spread of COVID-19 and caring for those infected is a public health priority, it is very important to maintain good coverage of immunisations, particularly in the childhood programme. In addition to protecting the individual, this will avoid outbreaks of vaccine-preventable diseases that could increase further the numbers of patients requiring health services.
Should people/babies really still go and be immunised at their GP surgery even though there is a risk that by doing this they may be infected with COVID-19?
Your GP surgery or health clinic will take all possible precautions to protect you and your baby from COVID-19. People should still attend for routine vaccinations unless they are unwell (check with your GP whether you should still attend) or self-isolating because they have been in contact with someone with COVID-19. In these circumstances please rearrange your appointment. Vaccines are the most effective way to prevent against other infectious diseases. Babies and toddlers in particular need vaccinations to protect them from measles, mumps, rubella (MMR), rotavirus, diphtheria, whooping cough, meningitis, polio, tetanus, hepatitis B, TB and more.
What are “routine” childhood immunisations?
The national immunisation programme is highly successful in reducing the incidence of serious and sometimes life-threatening diseases such as pneumococcal and meningococcal infections, whooping cough, diphtheria and measles. It remains important to maintain the best possible vaccine uptake to prevent a resurgence of these infections.
Practices will be prioritising the following:
- Routine childhood immunisations, from 8 weeks up to and including vaccines due at one year of age including first MMR and hepatitis B for at risk infants;
- Pertussis vaccination in pregnancy;
- Pneumococcal vaccination for those in risk groups from 2 to 64 years of age and those aged 65 years and over (subject to supplies of PPV23 and clinical prioritisation).
Neonatal BCG and all doses of targeted hepatitis B vaccines should also be offered in a timely manner.
If you are not doing school age immunisations, isn’t there a risk that we will see big increases in the diseases those children are normally vaccinated against?
School aged immunisations will be rescheduled. UK government has provided clear public health advice on specific measures to take to prevent further Coronavirus cases which includes social distancing. On this basis, community clinics are not recommended given that this is likely to increase the risk of exposure to the virus.
Do GP surgeries really still have the time to do immunisations?
Practices will be busy responding to the COVID-19 pandemic and the routine childhood immunisation programme will continue to play an important role in preventing ill-health through causes other than coronavirus infection.
How important is it that you get your immunisation at the time you are called? Is there a risk in delaying for a few months and if there isn’t then why don’t we stop and reduce the risk of contracting COVID-19 through a visit to the general practice?
Parents should be informed that despite the COVID-19 pandemic, it is important that routine childhood immunisations are started and completed on time. This will help protect the infant or child from a range of serious and sometimes life-threatening infections. Whilst infections such as invasive pneumococcal and meningococcal disease are now much reduced in incidence, this has only come about because of high levels of vaccination. To prevent resurgence, infants still need protecting through vaccination. Pertussis continues to circulate at elevated levels and it remains important that pregnant women are offered the pertussis vaccine, and that their babies start receiving protection against this, and other infections, from 8 weeks of age.
There is a shortage of liquid infant paracetamol which is often used by parents to help manage a baby’s reaction to their routine immunisations so won’t parents stop bringing their babies because of this?
Vaccination to protect from serious conditions should not be delayed. Whilst parents should continue to try to obtain and administer infant paracetamol if possible, infant vaccines can and should still be given even if it is not possible to give prophylactic paracetamol.
Where parents have been unable to obtain infant paracetamol, the following advice is for clinical staff in primary care and parents.
- Fever can be expected after any vaccination but is more common when the MenB vaccine (Bexsero) is given with the other routine vaccines at eight and sixteen weeks of age.
- In infants who do develop a fever after vaccination, the fever tends to peak around six hours after vaccination and is nearly always gone completely within two days.
- Ibuprofen can alternatively be used to treat a fever and other post-vaccination reactions. Prophylactic ibuprofen at the time of vaccination is not effective. Ibuprofen is not licensed for infants under the age of 3 months or body-weight under 5 kg. However, the BNF for Children advises that ibuprofen can be used for post-immunisation pyrexia in infants aged 2 to 3 months, on doctor’s advice only, using 50 mg for 1 dose, followed by 50 mg after 6 hours if required. See the BNF for Children for more details https://bnfc.nice.org.uk/drug/ibuprofen.html#indicationsAndDoses
- There have been concerns about the use of non-steroidal anti-inflammatory medications (NSAIDs) such as ibuprofen, in relation to COVID-19. This is being investigated by the Commission on Human Medicines and NICE. NHS England have advised in the interim for patients who have confirmed COVID-19, or believe they have COVID-19, that they use paracetamol in preference to NSAIDs. If parents cannot obtain their own supply of infant paracetamol and it has not been possible to prescribe it, as their baby will have been assessed as being well before vaccination, providing their baby has fever only and no symptoms consistent with COVID-19 infection, consideration should be given to using ibuprofen as described above. https://www.cas.mhra.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=103001
- Information about treating a fever in children is available from the NHS UK webpage “Fever in children” at www.nhs.uk/conditions/fever-in-children/
- If an infant still has a fever 48 hours after vaccination or if parents are concerned about their infant’s health at any time, they should seek advice from their GP or NHS 111.
- The diseases that the vaccines protect against are very serious and therefore vaccination should not be delayed because of concerns about post-vaccination fever.
How will parents know when their babies have a temperature after their regular immunisations whether it is an expected reaction or COVID-19?
Parents should be advised that the vaccines given may cause a fever which is usually resolved within 48 hours (or 6 to 11 days following MMR). This is a common expected reaction and isolation is not required, unless COVID-19 is suspected.
When the MenB vaccine (Bexsero) is given with other vaccines at 8 and 16 weeks of age, fever is more common. Where parents are able to obtain liquid infant paracetamol, they should follow existing PHE guidance on the use of prophylactic paracetamol following MenB vaccination available at: https://www.gov.uk/government/publications/menb-vaccine-and-paracetamol
Indications to date suggest that COVID-19 causes mild or asymptomatic illness in infants and children. As has always been recommended, any infant with fever after vaccination should be monitored and if parents are concerned about their infant’s health at any time, they should seek advice from their GP or NHS 111. Post-immunisation fever alone is not a reason to self-isolate.
This advice applies to recently vaccinated people of all ages.
Any infant with fever after vaccination should be monitored and if parents are concerned about their infant’s health at any time, they should seek advice from their GP or NHS 111.
Should people aged 70 and over attend the practice for immunisation?
It is recommended that PPV23 continues to be offered to eligible groups, including those aged 70 and over who have not previously been vaccinated. If an eligible individual aged 70 years and over attends the practice for other reasons, the opportunity to vaccinate them should be used. This may also present an opportunity to vaccinate them against shingles if they are eligible.
COVID-19 Privacy Notice
(This Privacy Notice is to run alongside our standard Practice Privacy Notice)
Due to the unprecedented challenges that the NHS and we Queens Bower Surgery face due to the worldwide COVID-19 pandemic, there is a greater need for public bodies to require additional collection and sharing of personal data to protect against serious threats to public health.
In order to look after your healthcare needs in the most efficient way we, Queens Bower Surgery may therefore need to share your personal information, including medical records, with staff from other GP Practices including Practices within our Primary Care Network, as well as other health organisations (i.e. Clinical Commissioning Groups, Commissioning Support Units, Local authorities etc.) and bodies engaged in disease surveillance for the purposes of research, protecting public health, providing healthcare services to the public and monitoring and managing the Covid-19 outbreak and incidents of exposure.
The Secretary of State has served notice under Regulation 3(4) of the Health Service (Control of Patient Information) Regulations 2002 (COPI) to require organisations to process confidential patient information in the manner set out below for purposes set out in Regulation 3(1) of COPI.
Purpose of this Notice
The purpose of this Notice is to require organisations such as Queens Bower Surgery to process confidential patient information for the purposes set out in Regulation 3(1) of COPI to support the Secretary of State’s response to Covid-19 (Covid-19 Purpose). “Processing” for these purposes is defined in Regulation 3(2) and includes dissemination of confidential patient information to persons and organisations permitted to process confidential patient information under Regulation 3(3) of COPI. This Notice is necessary to require organisations such as Queens Bower Surgery to lawfully and efficiently process confidential patient information as set out in Regulation 3(2) of COPI for purposes defined in regulation 3(1), for the purposes of research, protecting public health, providing healthcare services to the public and monitoring and managing the Covid-19 outbreak and incidents of exposure.
Requirement to Process Confidential Patient Information
The Secretary of State has served notice to recipients under Regulation 3(4) that requires Queens Bower Surgery to process confidential patient information, including disseminating to a person or organisation permitted to process confidential patient information under Regulation 3(3) of COPI.
Queens Bower Surgery is only required to process such confidential patient information:
- where the confidential patient information to be processed is required for a Covid-19 Purpose and will be processed solely for that Covid-19 Purpose in accordance with Regulation 7 of COPI
- from 20th March 2020 until 30th September 2020.
A Covid-19 Purpose includes but is not limited to the following:
- understanding Covid-19 and risks to public health, trends in Covid-19 and such risks, and controlling and preventing the spread of Covid-19 and such risks
- identifying and understanding information about patients or potential patients with or at risk of Covid-19, information about incidents of patient exposure to Covid-19 and the management of patients with or at risk of Covid-19 including: locating, contacting, screening, flagging and monitoring such patients and collecting information about and providing services in relation to testing, diagnosis, self-isolation, fitness to work, treatment, medical and social interventions and recovery from Covid-19
- understanding information about patient access to health services and adult social care services and the need for wider care of patients and vulnerable groups as a direct or indirect result of Covid-19 and the availability and capacity of those services or that care
- monitoring and managing the response to Covid-19 by health and social care bodies and the Government including providing information to the public about Covid-19 and its effectiveness and information about capacity, medicines, equipment, supplies, services and the workforce within the health services and adult social care services
- delivering services to patients, clinicians, the health services and adult social care services workforce and the public about and in connection with Covid-19, including the provision of information, fit notes and the provision of health care and adult social care services
- research and planning in relation to Covid-19.
Recording of processing
A record will be kept by Queens Bower Surgery of all data processed under this Notice.
Sending Public Health Messages
Data protection and electronic communication laws will not stop Queens Bower Surgery from sending public health messages to you, either by phone, text or email as these messages are not direct marketing.
It may also be necessary, where the latest technology allows Queens Bower Surgeryto do so, to use your information and health data to facilitate digital consultations and diagnoses and we will always do this with your security in mind.
Visitors to The Practice
We have an obligation to protect our staff and employees’ health, so it is reasonable for staff at Queens Bower Surgeryto ask any visitors to our practice to tell us if they have visited a particular country, or are experiencing COVID-19 symptoms. This must only be in pre-approved circumstances and we would also ask all patients to consider government advice on the NHS 111 website and not attend the practice.
Where it is necessary for us to collect information and specific health data about visitors to our practice, we will not collect more information than we need, and we will ensure that any information collected is treated with the appropriate safeguards.
Review and Expiry of this Notice
This Notice will be reviewed on or before 30 September 2020 and may be extended by The Secretary of State. If no further notice is sent to Queens Bower Surgery by The Secretary of State this Notice will expire on 30 September 2020.
GP Connect and the COVID outbreak – 08/04/2020
As a response to the COVID outbreak NHS England and NHS Digital have made some changes to the way GP connect works in general practice and fast-tracked some functionality to make it easier to share clinical information using an HTML view and appointment booking.
For a 12 month period your patient records will now be available to any 111 or Out-of–hours providers*
The CCG have instructed NHIS to switch HTML record access for all practices
Please note the implementation of GP Connect has been mandated by NHS England. In addition this has been considered by the CCG’s governance team and Practices are recommended to implement GP Connect to facilitate the necessary functionality but are asked to consider the operational arrangements about its use.
*The provider must have achieved the correct level of assurance with NHSD as per the Data Protection and Security toolkit within the last 12 months to be allowed to view the HTML record.